Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132


Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors.

Jia W, Kidoya H, Yamakawa D, Naito H, Takakura N.

Am J Pathol. 2013 May;182(5):1821-31. doi: 10.1016/j.ajpath.2013.01.017. Epub 2013 Mar 13.


Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages.

Linde N, Lederle W, Depner S, van Rooijen N, Gutschalk CM, Mueller MM.

J Pathol. 2012 May;227(1):17-28. doi: 10.1002/path.3989. Epub 2012 Mar 19.


Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages.

Machado CM, Andrade LN, Teixeira VR, Costa FF, Melo CM, dos Santos SN, Nonogaki S, Liu FT, Bernardes ES, Camargo AA, Chammas R.

Cancer Med. 2014 Apr;3(2):201-14. doi: 10.1002/cam4.173. Epub 2014 Jan 12.


Lack of galectin-3 alters the balance of innate immune cytokines and confers resistance to Rhodococcus equi infection.

Ferraz LC, Bernardes ES, Oliveira AF, Ruas LP, Fermino ML, Soares SG, Loyola AM, Oliver C, Jamur MC, Hsu DK, Liu FT, Chammas R, Roque-Barreira MC.

Eur J Immunol. 2008 Oct;38(10):2762-75. doi: 10.1002/eji.200737986.


Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth.

Muramatsu M, Yamamoto S, Osawa T, Shibuya M.

Cancer Res. 2010 Oct 15;70(20):8211-21. doi: 10.1158/0008-5472.CAN-10-0202. Epub 2010 Oct 5.


C-reactive protein reduces the relative number of tumor-associated M2 macrophages and intratumoral angiogenesis in mice.

Kuribayashi K, Motoyama S, Sasaki T, Sato Y, Yoshino K, Wakita A, Imai K, Saito H, Minamiya Y.

Tohoku J Exp Med. 2014 Aug;233(4):249-55.


Expression of galectin-3 in the tumor immune response in colon cancer.

Dumont P, Berton A, Nagy N, Sandras F, Tinton S, Demetter P, Mascart F, Allaoui A, Decaestecker C, Salmon I.

Lab Invest. 2008 Aug;88(8):896-906. doi: 10.1038/labinvest.2008.54. Epub 2008 Jun 9.


Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Nachtigal M, Ghaffar A, Mayer EP.

Am J Pathol. 2008 Jan;172(1):247-55. Epub 2007 Dec 21.


GAL3 protein expression is related to clinical features of prolactin-secreting pituitary microadenoma and predicts its recurrence after surgical treatment.

Dai D, Li Y, Lu Q, Yu L, Min W, Wang L, Cao Y, Yue Z.

Cell Physiol Biochem. 2014;33(4):1026-35. doi: 10.1159/000358673. Epub 2014 Apr 4.


Ethanol supports macrophage recruitment and reinforces invasion and migration of Lewis lung carcinoma.

Yu K, Yang J, Wang F, Chen L, Lu Y, Luo J, Wang S.

Alcohol Clin Exp Res. 2014 Oct;38(10):2597-606. doi: 10.1111/acer.12512.


Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.

Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A.

J Natl Cancer Inst. 2002 Dec 18;94(24):1854-62.


Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis.

Saegusa J, Hsu DK, Chen HY, Yu L, Fermin A, Fung MA, Liu FT.

Am J Pathol. 2009 Mar;174(3):922-31. doi: 10.2353/ajpath.2009.080500. Epub 2009 Jan 29.


The bone marrow compartment is modified in the absence of galectin-3.

Brand C, Oliveira FL, Ricon L, Fermino ML, Boldrini LC, Hsu DK, Liu FT, Chammas R, Borojevic R, Farina M, El-Cheikh MC.

Cell Tissue Res. 2011 Dec;346(3):427-37. doi: 10.1007/s00441-011-1276-5. Epub 2011 Nov 27.


Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells.

Hsu DK, Chernyavsky AI, Chen HY, Yu L, Grando SA, Liu FT.

J Invest Dermatol. 2009 Mar;129(3):573-83. doi: 10.1038/jid.2008.276. Epub 2008 Oct 9.


Hedgehog signaling pathway mediates tongue tumorigenesis in wild-type mice but not in Gal3-deficient mice.

de Oliveira Santos D, Loyola AM, Cardoso SV, Chammas R, Liu FT, de Faria PR.

Exp Mol Pathol. 2014 Dec;97(3):332-7. doi: 10.1016/j.yexmp.2014.09.018. Epub 2014 Sep 16.


Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages.

Sierra JR, Corso S, Caione L, Cepero V, Conrotto P, Cignetti A, Piacibello W, Kumanogoh A, Kikutani H, Comoglio PM, Tamagnone L, Giordano S.

J Exp Med. 2008 Jul 7;205(7):1673-85. doi: 10.1084/jem.20072602. Epub 2008 Jun 16.


Genetic deficiency in plasma protein HRG enhances tumor growth and metastasis by exacerbating immune escape and vessel abnormalization.

Tugues S, Honjo S, König C, Noguer O, Hedlund M, Botling J, Deschoemaeker S, Wenes M, Rolny C, Jahnen-Dechent W, Mazzone M, Claesson-Welsh L.

Cancer Res. 2012 Apr 15;72(8):1953-63. doi: 10.1158/0008-5472.CAN-11-2194. Epub 2012 Feb 28.


The role of tumor-associated macrophage in tumor progression.

Fukuda K, Kobayashi A, Watabe K.

Front Biosci (Schol Ed). 2012 Jan 1;4:787-98. Review.


Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.

Li P, Liu S, Lu M, Bandyopadhyay G, Oh D, Imamura T, Johnson AMF, Sears D, Shen Z, Cui B, Kong L, Hou S, Liang X, Iovino S, Watkins SM, Ying W, Osborn O, Wollam J, Brenner M, Olefsky JM.

Cell. 2016 Nov 3;167(4):973-984.e12. doi: 10.1016/j.cell.2016.10.025.

Supplemental Content

Support Center